Is anti-TNF therapeutic drug monitoring of value in IBD patients in clinical remission?

被引：0
|
作者：
Subramaniam, K. [1 ,2 ]
Watthayalage, R. [1 ]
Neeman, T. [3 ]
Pavli, P. [1 ,2 ]
机构：
[1] Canberra Hosp, Gastroenterol & Hepatol Unit, Canberra, ACT, Australia
[2] Australian Natl Univ, ANU Med Sch, Canberra, ACT, Australia
[3] Australian Natl Univ, Stat Consulting Unit, Canberra, ACT, Australia
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2016年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：149 / 149
页数：1
相关论文
共 50 条
  • [1] Is anti-TNF therapeutic drug monitoring of value in IBD patients in clinical remission?
    Subramaniam, K.
    Watthayalage, R.
    Neeman, T.
    Pavli, P.
    [J]. JOURNAL OF CROHNS & COLITIS, 2017, 11 : S353 - S353
  • [2] Clinical value of routine therapeutic anti-TNF drug monitoring (TDM) in Inflammatory Bowel Disease (IBD) patients in clinical practice
    Guirgis, M.
    Bianchetti, D.
    Dorta, G.
    Michetti, P.
    Maillard, M.
    [J]. JOURNAL OF CROHNS & COLITIS, 2015, 9 : S235 - S236
  • [3] A UK National Survey of Therapeutic Drug Monitoring With Anti-TNF Medications in IBD
    Nayeemuddin, Shadab
    Nigam, Gaurav B.
    Kontopantelis, Evangelos
    Hayee, Bu
    Limdi, Jimmy K.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S443 - S443
  • [4] A UK NATIONAL SURVEY OF THERAPEUTIC DRUG MONITORING WITH ANTI-TNF MEDICATIONS IN IBD
    Nayeemuddin, Shadab
    Nigam, Gaurav
    Kontopantelis, Evan
    Hayee, Bu
    Limdi, Jimmy
    [J]. GUT, 2019, 68 : A86 - A87
  • [5] Therapeutic drug monitoring of anti-TNFα drugs in a UK tertiary IBD unit
    Barrow, V.
    Innes, A.
    Thompson, N.
    Mansfield, J.
    Speight, A.
    [J]. JOURNAL OF CROHNS & COLITIS, 2017, 11 : S416 - S417
  • [6] Therapeutic Drug Monitoring in IBD: The New Standard-of-Care for Anti-TNF Therapy
    Papamichael, Konstantinos
    Cheifetz, Adam S.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 (05): : 673 - 676
  • [7] MAINTENANCE OF CLINICAL REMISSION IN IBD PATIENTS AFTER DISCONTINUATION OF ANTI-TNF AGENTS, AN ITALIAN EXPERIENCE
    Monterubbianesi, R.
    Furfaro, F.
    Costantino, G.
    Bezzio, C.
    Giannarelli, D.
    Fries, W.
    Maconi, G.
    Kohn, A.
    [J]. DIGESTIVE AND LIVER DISEASE, 2016, 48 : E158 - E158
  • [8] Editorial: is there a role for monitoring intermediate anti-TNF drug concentrations in IBD?
    Rakowsky, Shana
    Cheifetz, Adam S.
    Papamichael, Konstantinos
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (08) : 1049 - 1050
  • [9] Clinical Impact of Routine Anti-Tumour Necrosis Factor (Anti-TNF) Therapeutic Drug Monitoring (TDM) in Management of Inflammatory Bowel Disease (IBD) Patients
    Guirgis, Marianne
    Bianchetti, Davide
    Dorta, Gian O.
    Michetti, Pierre F.
    Maillard, Michel H.
    [J]. GASTROENTEROLOGY, 2015, 148 (04) : S857 - S858
  • [10] Clinical impact of routine anti-Tumour Necrosis Factor (anti-TNF) therapeutic drug monitoring (TDM) in the management of Inflammatory Bowel Disease (IBD) patients
    Guirgis, M.
    Bianchetti, D.
    Dorta, G.
    Michetti, P.
    Maillard, M.
    [J]. SWISS MEDICAL WEEKLY, 2015, 145 : S3 - S3
12345